Colorectal Cancer Molecular Diagnostics Market

Colorectal cancer molecular diagnostics can speed up the identification of colorectal cancer to provide patients with more treatment options. Individualized and targeted treatments are reshaping the colorectal molecular diagnostics market. Molecular pathology is a key factor to personalized medicine. Increasing adoption of high throughput sequencing technologies and identification of therapeutic targets has led to the development of many colorectal molecular diagnostic tests, which are superior to the conventional colorectal cancer molecular diagnostics tests.
Colorectal Cancer Molecular Diagnostics Market contains market size and forecasts of Colorectal Cancer Molecular Diagnostics in Global, including the following market information:
Global Colorectal Cancer Molecular Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Colorectal Cancer Molecular Diagnostics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
PCR Diagnostics Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Colorectal Cancer Molecular Diagnostics include Agilent, Hologic, Qiagen, Roche, Bayer, Abbott, Grifols, Danaher and Siemens, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Colorectal Cancer Molecular Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Colorectal Cancer Molecular Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Colorectal Cancer Molecular Diagnostics Market Segment Percentages, by Type, 2021 (%)
PCR Diagnostics
Mass spectrometry Diagnostics
Others
Global Colorectal Cancer Molecular Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Colorectal Cancer Molecular Diagnostics Market Segment Percentages, by Application, 2021 (%)
Hospitals
Ambulatory Surgical Centers
Diagnostic Laboratories
Global Colorectal Cancer Molecular Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Colorectal Cancer Molecular Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Colorectal Cancer Molecular Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Colorectal Cancer Molecular Diagnostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Agilent
Hologic
Qiagen
Roche
Bayer
Abbott
Grifols
Danaher
Siemens
BD
Biom?rieux
Sysmex